12:00 AM
Apr 29, 2013
 |  BC Week In Review  |  Financial News  |  Amended Offerings

Idera amends follow-on

Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass.
Business: Cancer, Infectious, Autoimmune
Date announced: 4/23/13
Type: Follow-on
To be...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >